131 related articles for article (PubMed ID: 28714946)
1. Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality.
Innes AJ; Mullish BH; Fernando F; Adams G; Marchesi JR; Apperley JF; Brannigan E; Davies F; Pavlů J
Bone Marrow Transplant; 2017 Oct; 52(10):1452-1454. PubMed ID: 28714946
[No Abstract] [Full Text] [Related]
2. Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
Campana D; Pui CH
Blood; 2017 Apr; 129(14):1913-1918. PubMed ID: 28167658
[No Abstract] [Full Text] [Related]
3. Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
Saito T; Seo S; Kanda Y; Shoji N; Ogasawara T; Murakami J; Tanosaki R; Tobinai K; Takaue Y; Mineishi S
Am J Hematol; 2001 Jul; 67(3):206-9. PubMed ID: 11391721
[TBL] [Abstract][Full Text] [Related]
4. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
Locatelli F; Zecca M; Messina C; Rondelli R; Lanino E; Sacchi N; Uderzo C; Fagioli F; Conter V; Bonetti F; Favre C; Porta F; Giorgiani G; Pession A
Leukemia; 2002 Nov; 16(11):2228-37. PubMed ID: 12399966
[TBL] [Abstract][Full Text] [Related]
5. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
Bonney D; Razali H; Turner A; Will A
Br J Haematol; 2009 Jun; 145(5):667-9. PubMed ID: 19344395
[No Abstract] [Full Text] [Related]
7. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
[TBL] [Abstract][Full Text] [Related]
8. bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
Abla O; Gassas A; Stevens R; Grant R; Abdelhaleem M
J Pediatr Hematol Oncol; 2006 Feb; 28(2):98-9. PubMed ID: 16462583
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
Chybicka A; Bogusławska-Jaworska J; Gorczyńska E; Juszczak K; Armata J; Balcerska A; Balwierz W; Bubała H; Filiks-Litwin B; Kołecki P; Kowalczyk J; Lukowska K; Matysiak M; Rokicka-Milewska R; Rola-Kurc E; Stencel D; Sońta-Jakimczyk D; Strojny W; Wachowiak J; Wieczorek M; Wysocki M; Zelenay E
Wiad Lek; 1998; 51 Suppl 4():25-32. PubMed ID: 10731940
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of children with acute lymphoblastic leukemia].
Pinkel' D
Gematol Transfuziol; 1991 Jan; 36(1):12-6. PubMed ID: 2065938
[No Abstract] [Full Text] [Related]
11. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
[No Abstract] [Full Text] [Related]
12. [Acute leukemia in Jehovah's Witnesses].
Bueno J; Zuazu J; Villalba T; Julià A
Sangre (Barc); 1999 Oct; 44(5):381-2. PubMed ID: 10618916
[TBL] [Abstract][Full Text] [Related]
13. [The programmed therapy of acute lymphoblastic leukemia in adults].
Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
[No Abstract] [Full Text] [Related]
14. [Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
Fu RY; Liao QK; Jia CS
Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):515-9. PubMed ID: 14746678
[No Abstract] [Full Text] [Related]
15. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
Ortega JJ; Javier G; Olivé T
An Esp Pediatr; 1988 Oct; 29 Suppl 34():72-83. PubMed ID: 3214043
[No Abstract] [Full Text] [Related]
16. [Treatment of adult acute lymphoblastic leukemia with DCVP-l-asp protocol].
Murata M; Nagai M; Tasaka T; Ohnishi H; Sasaki K; Taoka T; Ikeda K; Kubota Y; Tanaka T; Takahara J
Rinsho Ketsueki; 1993 Mar; 34(3):307-12. PubMed ID: 8479082
[TBL] [Abstract][Full Text] [Related]
17. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
Jakab Z; Balogh E; Karászi E; Kappelmayer J; Kiss C; Oláh E
Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086
[No Abstract] [Full Text] [Related]
18. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
[No Abstract] [Full Text] [Related]
19. Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
Mughal T; Morleda J; Goldman J
Acta Haematol; 1993; 89(3):149-51. PubMed ID: 8362603
[TBL] [Abstract][Full Text] [Related]
20. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
